Skip to main content

Table 4 Predictors of development of early ascites based on multivariate Cox regression, censoring the time of follow-up at death, early ascites, or second DEB-TACE

From: The development of early ascites is associated with shorter overall survival in patients with hepatocellular carcinoma treated with drug-eluting embolic chemoembolization

 

p-value

Exp(B)

Exp(B) 95% CI

Lower

Higher

CSPH (yes/no)

0.35

0.34

0.05

2.99

Esophageal varices (yes/no)

0.43

0.61

0.1

2.10

BCLC 0/ A (yes/no)

0.20

1.80

0.730

4.46

Bilirubin

0.15

1.53

0.85

2.74

Hemoglobin

0.01

0.66

0.49

0.89

Child A5 (yes / no)

0.001

0.22

0.09

0.53

Albumin

0.03

0.31

0.11

0.88

Ascites prior to DEB-TACE

< 0.001

0.12

0.04

0.32

  1. Model 1: Child A 5 plus Hemoglobin; Model 2: Hemoglobin plus prior ascites plus albumin
  2. CSPH Clinically significant portal hypertension
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us